Monitoring glycemia in diabetes.

Monitoring of glycemic control is a key component of the diabetes treatment plan. Patients who are not meeting targets often require more intensive monitoring, ranging from frequent self-monitored glucose to continuous glucose monitoring in order to facilitate medication and lifestyle changes. However, more intensive monitoring demands more training and a structured plan for interpretation and use of the data. Better patient and provider tools to support decision-making and progress toward an artificial pancreas may help to alleviate this burden.

[1]  Christina Schmid,et al.  System Accuracy Evaluation of 43 Blood Glucose Monitoring Systems for Self-Monitoring of Blood Glucose according to DIN EN ISO 15197 , 2012, Journal of diabetes science and technology.

[2]  D. Klonoff,et al.  Continuous glucose monitoring: an Endocrine Society Clinical Practice Guideline. , 2011, The Journal of clinical endocrinology and metabolism.

[3]  G. Charpentier,et al.  The Diabeo Software Enabling Individualized Insulin Dose Adjustments Combined With Telemedicine Support Improves HbA1c in Poorly Controlled Type 1 Diabetic Patients , 2011, Diabetes Care.

[4]  M. O'Kane,et al.  Comparing patient generated blood glucose diary records with meter memory in type 2 diabetes. , 2014, Diabetes research and clinical practice.

[5]  Howard Wolpert,et al.  Factors Predictive of Use and of Benefit From Continuous Glucose Monitoring in Type 1 Diabetes , 2009, Diabetes Care.

[6]  D. Nathan,et al.  Relationship of Glycated Albumin to Blood Glucose and HbA1c Values and to Retinopathy, Nephropathy, and Cardiovascular Outcomes in the DCCT/EDIC Study , 2013, Diabetes.

[7]  E. Kilpatrick,et al.  Relating mean blood glucose and glucose variability to the risk of multiple episodes of hypoglycaemia in type 1 diabetes , 2007, Diabetologia.

[8]  B Shashaj,et al.  Benefits of a bolus calculator in pre‐ and postprandial glycaemic control and meal flexibility of paediatric patients using continuous subcutaneous insulin infusion (CSII) , 2008, Diabetic medicine : a journal of the British Diabetic Association.

[9]  Adam Jaffe,et al.  Noninvasive Monitoring of Glucose Levels: Is Exhaled Breath the Answer? , 2012, Journal of diabetes science and technology.

[10]  L. Welschen,et al.  Self-monitoring of blood glucose in patients with type 2 diabetes mellitus who are not using insulin. , 2012, The Cochrane database of systematic reviews.

[11]  Giacomo Vespasiani,et al.  Telecare Provides comparable efficacy to conventional self-monitored blood glucose in patients with type 2 diabetes titrating one injection of insulin glulisine-the ELEONOR study. , 2012, Diabetes technology & therapeutics.

[12]  A. Jenkins,et al.  An algorithm guiding patient responses to real-time-continuous glucose monitoring improves quality of life. , 2011, Diabetes technology & therapeutics.

[13]  D. Schoenfeld,et al.  Translating the A1C Assay Into Estimated Average Glucose Values , 2008, Diabetes Care.

[14]  E. Bass,et al.  Comparative Effectiveness and Safety of Methods of Insulin Delivery and Glucose Monitoring for Diabetes Mellitus , 2012, Annals of Internal Medicine.

[15]  William Hodge,et al.  Noninvasive Diagnostic Devices for Diabetes through Measuring Tear Glucose , 2011, Journal of diabetes science and technology.

[16]  J. McGill,et al.  Evidence of a Strong Association Between Frequency of Self-Monitoring of Blood Glucose and Hemoglobin A1c Levels in T1D Exchange Clinic Registry Participants , 2013, Diabetes Care.

[17]  Howard Zisser,et al.  Accuracy of the Enlite 6-day glucose sensor with guardian and Veo calibration algorithms. , 2012, Diabetes technology & therapeutics.

[18]  F. Kaufman,et al.  Accuracy of the Sof-Sensor Glucose Sensor with the iPro Calibration Algorithm , 2012, Journal of diabetes science and technology.

[19]  J. Rosenbauer,et al.  Frequency of SMBG correlates with HbA1c and acute complications in children and adolescents with type 1 diabetes , 2011, Pediatric diabetes.

[20]  K. Dungan Predicting outcomes and assessing control with alternate glycemic markers. , 2012, Diabetes technology & therapeutics.

[21]  M. Phillip,et al.  Effect of Continuous Glucose Monitoring on Hypoglycemia in Type 1 Diabetes , 2011, Diabetes Care.

[22]  E. Beverly,et al.  The effect of a structured behavioral intervention on poorly controlled diabetes: a randomized controlled trial. , 2011, Archives of internal medicine.

[23]  R. Little,et al.  Status of hemoglobin A1c measurement and goals for improvement: from chaos to order for improving diabetes care. , 2011, Clinical chemistry.

[24]  J. Mahoney,et al.  Automated Glycemic Pattern Analysis Can Improve Health Care Professional Efficiency and Accuracy , 2013, Journal of diabetes science and technology.

[25]  I. Hirsch,et al.  Statement by the American Association of Clinical Endocrinologists Consensus Panel on continuous glucose monitoring. , 2010, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[26]  Charles M Peterson,et al.  Tests of glycemia in diabetes. , 1995, Diabetes care.

[27]  J. Pickup The Evidence Base for Diabetes Technology: Appropriate and Inappropriate Meta-Analysis , 2013, Journal of diabetes science and technology.

[28]  George Dailey,et al.  Assessing glycemic control with self-monitoring of blood glucose and hemoglobin A(1c) measurements. , 2007, Mayo Clinic proceedings.

[29]  A. Farmer,et al.  Meta-analysis of individual patient data in randomised trials of self monitoring of blood glucose in people with non-insulin treated type 2 diabetes , 2012, BMJ : British Medical Journal.

[30]  K. Barnard,et al.  Use of an Insulin Bolus Advisor Improves Glycemic Control in Multiple Daily Insulin Injection (MDI) Therapy Patients With Suboptimal Glycemic Control , 2013, Diabetes Care.

[31]  Michael O'Grady,et al.  Continuous glucose monitoring and intensive treatment of type 1 diabetes. , 2008, The New England journal of medicine.

[32]  Lotty Hooft,et al.  Continuous glucose monitoring systems for type 1 diabetes mellitus. , 2012, The Cochrane database of systematic reviews.

[33]  Elizabeth Selvin,et al.  Fructosamine and glycated albumin for risk stratification and prediction of incident diabetes and microvascular complications: a prospective cohort analysis of the Atherosclerosis Risk in Communities (ARIC) study. , 2014, The lancet. Diabetes & endocrinology.

[34]  Baseline predictors of A1C reduction in adults using sensor-augmented pump therapy or multiple daily injection therapy: the STAR 3 experience. , 2011, Diabetes technology & therapeutics.

[35]  D. Klonoff,et al.  Threshold-based insulin-pump interruption for reduction of hypoglycemia. , 2013, The New England journal of medicine.

[36]  N. Clark,et al.  Standards of Medical Care in Diabetes: Response to Power , 2006 .

[37]  Z. Bloomgarden,et al.  Review of hemoglobin A1c in the management of diabetes , 2009, Journal of diabetes.

[38]  David Kerr,et al.  Consensus Report: The Current Role of Self-Monitoring of Blood Glucose in Non-Insulin-Treated Type 2 Diabetes , 2011, Journal of diabetes science and technology.

[39]  W. Grzeszczak,et al.  Addressing schemes of self-monitoring of blood glucose in type 2 diabetes: a European perspective and expert recommendation. , 2011, Diabetes technology & therapeutics.

[40]  Thomas Peyser,et al.  A new-generation continuous glucose monitoring system: improved accuracy and reliability compared with a previous-generation system. , 2013, Diabetes technology & therapeutics.

[41]  J. Hans DeVries,et al.  Accuracy and reliability of continuous glucose monitoring systems: a head-to-head comparison. , 2013, Diabetes technology & therapeutics.

[42]  K. Nørgaard,et al.  Routine sensor-augmented pump therapy in type 1 diabetes: the INTERPRET study. , 2013, Diabetes technology & therapeutics.

[43]  Paolo Pozzilli,et al.  A novel insulin unit calculator for the management of type 1 diabetes. , 2011, Diabetes technology & therapeutics.

[44]  R. Rubin,et al.  Health-related quality of life and treatment satisfaction in the Sensor-Augmented Pump Therapy for A1C Reduction 3 (STAR 3) trial. , 2012, Diabetes technology & therapeutics.

[45]  Alex J Sutton,et al.  Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self monitoring of blood glucose: meta-analysis of randomised controlled trials using individual patient data , 2011, BMJ : British Medical Journal.

[46]  Ronald Tamler,et al.  An evaluation of diabetes self-management applications for Android smartphones , 2012, Journal of telemedicine and telecare.

[47]  R. Little,et al.  A Review of Variant Hemoglobins Interfering with Hemoglobin A1c Measurement , 2009, Journal of diabetes science and technology.

[48]  R. Beck Effectiveness of Continuous Glucose Monitoring in a Clinical Care Environment , 2009, Diabetes Care.

[49]  W. Polonsky,et al.  Structured Self-Monitoring of Blood Glucose Significantly Reduces A1C Levels in Poorly Controlled, Noninsulin-Treated Type 2 Diabetes , 2011, Diabetes Care.

[50]  Tadej Battelino,et al.  Self-Monitoring of Blood Glucose in Type 2 Diabetes: Recent Studies , 2013, Journal of diabetes science and technology.

[51]  Roy Beck,et al.  Use of the DirecNet Applied Treatment Algorithm (DATA) for diabetes management with a real‐time continuous glucose monitor (the FreeStyle Navigator) , 2008, Pediatric diabetes.

[52]  Christopher G Parkin,et al.  Value of Self-Monitoring Blood Glucose Pattern Analysis in Improving Diabetes Outcomes , 2009, Journal of diabetes science and technology.

[53]  George Dailey,et al.  Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes. , 2010, The New England journal of medicine.

[54]  Christina Schmid,et al.  Evaluation of 12 blood glucose monitoring systems for self-testing: system accuracy and measurement reproducibility. , 2014, Diabetes technology & therapeutics.